Emc Capital Management Esperion Therapeutics, Inc. Transaction History

Emc Capital Management

  • $152 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$4.81 - $11.92 $132,592 - $328,586
-27,566 Closed
0 $0
Q2 2021

Aug 09, 2021
SELL
$19.4 - $28.71 $8,322 - $12,316
-429 Reduced 1.53%
27,566 $583,000
Q1 2021

May 05, 2021
BUY
$25.12 - $36.89 $346,605 - $509,008
13,798 Added 97.19%
27,995 $785,000
Q4 2020

Feb 24, 2021
BUY
$24.2 - $35.76 $343,567 - $507,684
14,197 New
14,197 $369,000

Others Institutions Holding ESPR

# of Institutions
207
Shares Held
128M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $168M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Emc Capital Management Portfolio

Follow Emc Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emc Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Emc Capital Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email